Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf1a
|
ENSMUSG00000029556.6 | HNF1 homeobox A |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_114970774_114971288 | Hnf1a | 36 | 0.922386 | 0.92 | 1.3e-22 | Click! |
chr5_114971329_114971627 | Hnf1a | 384 | 0.662307 | 0.84 | 8.0e-16 | Click! |
chr5_114970582_114970733 | Hnf1a | 187 | 0.792557 | 0.65 | 7.5e-08 | Click! |
chr5_114972237_114972388 | Hnf1a | 1218 | 0.237218 | 0.65 | 9.1e-08 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_59212186_59212347 | 54.88 |
Als2 |
alsin Rho guanine nucleotide exchange factor |
6860 |
0.17 |
chr17_55903813_55903973 | 54.49 |
Zfp959 |
zinc finger protein 959 |
11425 |
0.1 |
chr7_110088063_110088458 | 52.27 |
Zfp143 |
zinc finger protein 143 |
3369 |
0.16 |
chr8_33987076_33987405 | 48.09 |
Gm45817 |
predicted gene 45817 |
40 |
0.96 |
chr10_75429110_75429286 | 46.16 |
Upb1 |
ureidopropionase, beta |
1017 |
0.5 |
chr5_28501122_28501421 | 44.45 |
Shh |
sonic hedgehog |
34015 |
0.14 |
chr6_72961689_72961879 | 44.43 |
Tmsb10 |
thymosin, beta 10 |
3036 |
0.2 |
chr14_73253542_73253713 | 43.68 |
Rb1 |
RB transcriptional corepressor 1 |
10694 |
0.17 |
chr1_125676771_125677048 | 43.05 |
Gpr39 |
G protein-coupled receptor 39 |
86 |
0.98 |
chr13_24879758_24879991 | 42.66 |
D130043K22Rik |
RIKEN cDNA D130043K22 gene |
651 |
0.62 |
chr9_102734789_102734975 | 42.43 |
Amotl2 |
angiomotin-like 2 |
4151 |
0.14 |
chr5_89218247_89218635 | 42.27 |
Slc4a4 |
solute carrier family 4 (anion exchanger), member 4 |
190349 |
0.03 |
chr5_138089120_138089321 | 42.15 |
Zkscan1 |
zinc finger with KRAB and SCAN domains 1 |
3420 |
0.11 |
chr14_25452158_25452322 | 41.66 |
Zmiz1os1 |
Zmiz1 opposite strand 1 |
5558 |
0.14 |
chr14_73106935_73107379 | 41.10 |
Rcbtb2 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
15880 |
0.2 |
chr15_38640886_38641047 | 40.32 |
1100001I12Rik |
RIKEN cDNA 1100001I12 gene |
18873 |
0.14 |
chr11_108251302_108251514 | 38.58 |
Gm11655 |
predicted gene 11655 |
69558 |
0.1 |
chr14_65855315_65855627 | 38.38 |
Ccdc25 |
coiled-coil domain containing 25 |
18111 |
0.17 |
chr3_37748011_37748362 | 38.32 |
Gm42921 |
predicted gene 42921 |
12851 |
0.11 |
chr6_138351080_138351249 | 38.30 |
Lmo3 |
LIM domain only 3 |
70288 |
0.11 |
chr14_69321815_69322332 | 38.17 |
Gm16677 |
predicted gene, 16677 |
15009 |
0.09 |
chr14_69540059_69540582 | 38.16 |
Gm27174 |
predicted gene 27174 |
15012 |
0.09 |
chr7_138538334_138538498 | 38.16 |
4930543N07Rik |
RIKEN cDNA 4930543N07 gene |
15814 |
0.26 |
chr13_37896000_37896178 | 36.91 |
Rreb1 |
ras responsive element binding protein 1 |
7218 |
0.23 |
chr17_84156966_84157484 | 36.58 |
Gm19696 |
predicted gene, 19696 |
785 |
0.6 |
chr6_86765867_86766067 | 36.16 |
Anxa4 |
annexin A4 |
57 |
0.96 |
chr6_31129270_31129431 | 35.82 |
Gm13835 |
predicted gene 13835 |
13313 |
0.12 |
chr19_4033370_4033521 | 35.59 |
Gstp1 |
glutathione S-transferase, pi 1 |
2548 |
0.09 |
chr15_85771762_85772137 | 35.35 |
Ppara |
peroxisome proliferator activated receptor alpha |
265 |
0.89 |
chr17_30136842_30137085 | 35.15 |
Zfand3 |
zinc finger, AN1-type domain 3 |
773 |
0.65 |
chr10_127763876_127764285 | 34.96 |
Rdh16f1 |
RDH16 family member 1 |
4293 |
0.09 |
chr1_133309702_133309900 | 34.45 |
Golt1a |
golgi transport 1A |
1 |
0.5 |
chr12_31256586_31256763 | 34.42 |
Gm32899 |
predicted gene, 32899 |
2183 |
0.18 |
chr15_95838544_95838755 | 34.34 |
Gm17546 |
predicted gene, 17546 |
8577 |
0.15 |
chr8_127441166_127441496 | 34.25 |
Pard3 |
par-3 family cell polarity regulator |
6415 |
0.32 |
chr5_5533675_5533826 | 33.85 |
Gtpbp10 |
GTP-binding protein 10 (putative) |
9696 |
0.15 |
chr3_121530937_121531224 | 33.84 |
A530020G20Rik |
RIKEN cDNA A530020G20 gene |
539 |
0.67 |
chrX_139640577_139640728 | 33.71 |
Rnf128 |
ring finger protein 128 |
29285 |
0.15 |
chr12_80929028_80929193 | 33.41 |
1700052I22Rik |
RIKEN cDNA 1700052I22 gene |
4661 |
0.15 |
chr2_147968629_147969002 | 33.17 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
7370 |
0.24 |
chr5_137455811_137456157 | 32.79 |
Zan |
zonadhesin |
5361 |
0.1 |
chr12_103737920_103738559 | 32.69 |
Serpina1b |
serine (or cysteine) preptidase inhibitor, clade A, member 1B |
81 |
0.95 |
chr13_114680541_114680791 | 32.62 |
4930544M13Rik |
RIKEN cDNA 4930544M13 gene |
73429 |
0.09 |
chr12_69783334_69783550 | 32.34 |
4930512B01Rik |
RIKEN cDNA 4930512B01 gene |
6846 |
0.13 |
chr8_22390855_22391028 | 32.07 |
Slc25a15 |
solute carrier family 25 (mitochondrial carrier ornithine transporter), member 15 |
7603 |
0.11 |
chr5_146692710_146692949 | 31.79 |
4930573C15Rik |
RIKEN cDNA 4930573C15 gene |
13793 |
0.17 |
chr1_136911165_136911329 | 31.72 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
29336 |
0.18 |
chr14_68460485_68460813 | 31.64 |
Gm31227 |
predicted gene, 31227 |
982 |
0.64 |
chr10_115263315_115263511 | 31.57 |
Gm8942 |
predicted gene 8942 |
6565 |
0.17 |
chr7_79842295_79842494 | 31.57 |
Anpep |
alanyl (membrane) aminopeptidase |
42 |
0.96 |
chr13_70866959_70867347 | 31.01 |
8030423J24Rik |
RIKEN cDNA 8030423J24 gene |
15795 |
0.19 |
chr10_93899367_93899518 | 30.90 |
4930471D02Rik |
RIKEN cDNA 4930471D02 gene |
2284 |
0.19 |
chr1_86176075_86176228 | 30.74 |
Armc9 |
armadillo repeat containing 9 |
20239 |
0.12 |
chr5_63847642_63847841 | 30.72 |
0610040J01Rik |
RIKEN cDNA 0610040J01 gene |
28568 |
0.17 |
chr4_135335777_135335991 | 30.35 |
Srrm1 |
serine/arginine repetitive matrix 1 |
2189 |
0.2 |
chr10_40078089_40078257 | 30.11 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
1568 |
0.32 |
chr12_103863072_103863984 | 29.67 |
Serpina1a |
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
23 |
0.95 |
chr2_128714932_128715156 | 29.50 |
Mertk |
MER proto-oncogene tyrosine kinase |
16088 |
0.14 |
chr2_103144443_103144797 | 29.49 |
Gm13874 |
predicted gene 13874 |
33167 |
0.13 |
chr13_109502878_109503073 | 29.44 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
60792 |
0.16 |
chr13_4233586_4233793 | 29.27 |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
51 |
0.97 |
chr12_75706830_75707001 | 29.22 |
Sgpp1 |
sphingosine-1-phosphate phosphatase 1 |
28781 |
0.17 |
chr2_125615804_125616138 | 29.12 |
Cep152 |
centrosomal protein 152 |
9142 |
0.22 |
chr11_64542430_64542585 | 28.87 |
Gm24275 |
predicted gene, 24275 |
48133 |
0.18 |
chr13_54701326_54701509 | 28.69 |
Cdhr2 |
cadherin-related family member 2 |
44 |
0.96 |
chr9_92266891_92267068 | 28.69 |
Mir6386 |
microRNA 6386 |
382 |
0.64 |
chr2_91832253_91832588 | 28.36 |
Ambra1 |
autophagy/beclin 1 regulator 1 |
20752 |
0.16 |
chr10_80975511_80975708 | 28.23 |
Gm3828 |
predicted gene 3828 |
20899 |
0.08 |
chr2_115520093_115520270 | 28.21 |
3110099E03Rik |
RIKEN cDNA 3110099E03 gene |
7563 |
0.25 |
chr17_83999191_83999431 | 28.13 |
8430430B14Rik |
RIKEN cDNA 8430430B14 gene |
757 |
0.52 |
chr6_50553038_50553204 | 28.12 |
Cycs |
cytochrome c, somatic |
12828 |
0.1 |
chr12_80103423_80104027 | 28.03 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
9269 |
0.12 |
chr4_53596437_53596608 | 27.98 |
Slc44a1 |
solute carrier family 44, member 1 |
417 |
0.84 |
chr4_107899249_107899588 | 27.90 |
Czib |
CXXC motif containing zinc binding protein |
6048 |
0.13 |
chr8_124248816_124249016 | 27.82 |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
17408 |
0.17 |
chr1_87294458_87294622 | 27.65 |
Efhd1 |
EF hand domain containing 1 |
14686 |
0.12 |
chr7_35372700_35372880 | 27.55 |
Rhpn2 |
rhophilin, Rho GTPase binding protein 2 |
6492 |
0.14 |
chr16_17345528_17345803 | 27.37 |
Gm24927 |
predicted gene, 24927 |
3653 |
0.15 |
chr11_7197502_7197878 | 27.18 |
Igfbp1 |
insulin-like growth factor binding protein 1 |
92 |
0.97 |
chr10_111595486_111595932 | 27.14 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
1436 |
0.36 |
chr3_84283495_84283832 | 27.13 |
Trim2 |
tripartite motif-containing 2 |
12872 |
0.25 |
chr16_94629066_94629238 | 27.06 |
Gm15971 |
predicted gene 15971 |
8775 |
0.21 |
chr18_67765528_67765745 | 26.95 |
Gm26910 |
predicted gene, 26910 |
9221 |
0.15 |
chr16_46849656_46849858 | 26.91 |
Gm6912 |
predicted gene 6912 |
224441 |
0.02 |
chr2_156951420_156951582 | 26.74 |
Ndrg3 |
N-myc downstream regulated gene 3 |
1892 |
0.21 |
chr2_115450302_115450457 | 26.32 |
3110099E03Rik |
RIKEN cDNA 3110099E03 gene |
61822 |
0.12 |
chr11_75904994_75905319 | 26.14 |
Rph3al |
rabphilin 3A-like (without C2 domains) |
5906 |
0.21 |
chr17_63973867_63974125 | 26.08 |
Fer |
fer (fms/fps related) protein kinase |
36024 |
0.22 |
chr5_147017681_147017832 | 25.67 |
Lnx2 |
ligand of numb-protein X 2 |
1279 |
0.44 |
chr1_172990176_172990333 | 25.54 |
Olfr16 |
olfactory receptor 16 |
33486 |
0.13 |
chr10_82848220_82848371 | 25.43 |
Gm47073 |
predicted gene, 47073 |
4352 |
0.14 |
chr8_48603571_48603731 | 25.42 |
Gm45772 |
predicted gene 45772 |
27518 |
0.22 |
chr14_105427732_105427928 | 25.28 |
5430440P10Rik |
RIKEN cDNA 5430440P10 gene |
271 |
0.93 |
chr3_41581534_41581748 | 25.22 |
Jade1 |
jade family PHD finger 1 |
785 |
0.6 |
chr9_71689782_71689979 | 25.21 |
Cgnl1 |
cingulin-like 1 |
41530 |
0.15 |
chr8_117334497_117335149 | 25.18 |
Cmip |
c-Maf inducing protein |
14347 |
0.24 |
chr11_83819878_83820106 | 25.13 |
Gm11434 |
predicted gene 11434 |
19528 |
0.11 |
chr4_59387864_59388177 | 25.13 |
Gm12527 |
predicted gene 12527 |
19154 |
0.18 |
chr2_172901314_172901694 | 25.03 |
Gm22773 |
predicted gene, 22773 |
37163 |
0.14 |
chr7_142529125_142529276 | 24.84 |
Mrpl23 |
mitochondrial ribosomal protein L23 |
3486 |
0.13 |
chr6_54600780_54600942 | 24.71 |
Plekha8 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8 |
2286 |
0.25 |
chr6_86978664_86978831 | 24.71 |
Gm44091 |
predicted gene, 44091 |
2218 |
0.22 |
chr7_79305919_79306070 | 24.61 |
Gm39041 |
predicted gene, 39041 |
6969 |
0.15 |
chr18_3335335_3335498 | 24.59 |
Gm6225 |
predicted gene 6225 |
1264 |
0.38 |
chr14_34760063_34760234 | 24.41 |
A930038B10Rik |
RIKEN cDNA A930038B10 gene |
79 |
0.96 |
chr1_64787464_64787940 | 24.10 |
Plekhm3 |
pleckstrin homology domain containing, family M, member 3 |
49062 |
0.1 |
chr13_96432348_96432811 | 23.97 |
Ankdd1b |
ankyrin repeat and death domain containing 1B |
3373 |
0.2 |
chr17_42909095_42909404 | 23.92 |
Cd2ap |
CD2-associated protein |
32584 |
0.22 |
chr2_163506695_163506887 | 23.91 |
Hnf4a |
hepatic nuclear factor 4, alpha |
17 |
0.96 |
chr1_136228974_136229345 | 23.88 |
Inava |
innate immunity activator |
860 |
0.42 |
chr1_133214065_133214256 | 23.61 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
31937 |
0.13 |
chr14_120271077_120271397 | 23.54 |
Mbnl2 |
muscleblind like splicing factor 2 |
4432 |
0.3 |
chr5_105801311_105801483 | 23.52 |
Rps15a-ps5 |
ribosomal protein S15A, pseudogene 5 |
3684 |
0.19 |
chr3_97756693_97757073 | 23.49 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
11048 |
0.18 |
chr5_66042824_66043219 | 23.30 |
Rbm47 |
RNA binding motif protein 47 |
11531 |
0.12 |
chr17_85041012_85041216 | 23.09 |
Slc3a1 |
solute carrier family 3, member 1 |
12738 |
0.18 |
chr7_25450305_25450456 | 22.92 |
Gm15495 |
predicted gene 15495 |
6917 |
0.11 |
chr5_114969610_114969761 | 22.92 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
212 |
0.77 |
chr4_57282767_57282979 | 22.89 |
Gm12536 |
predicted gene 12536 |
17223 |
0.18 |
chr15_99862572_99862773 | 22.82 |
Lima1 |
LIM domain and actin binding 1 |
11999 |
0.08 |
chr8_20817574_20818579 | 22.79 |
Gm20946 |
predicted gene, 20946 |
10277 |
0.15 |
chr18_73787184_73787366 | 22.71 |
Me2 |
malic enzyme 2, NAD(+)-dependent, mitochondrial |
28163 |
0.14 |
chr12_108887075_108887226 | 22.61 |
Wars |
tryptophanyl-tRNA synthetase |
1267 |
0.3 |
chr7_101083858_101084024 | 22.57 |
Fchsd2 |
FCH and double SH3 domains 2 |
8922 |
0.16 |
chr10_53382724_53383006 | 22.51 |
Cep85l |
centrosomal protein 85-like |
2918 |
0.17 |
chr11_115911824_115912039 | 22.51 |
Smim6 |
small integral membrane protein 6 |
86 |
0.93 |
chr2_173977680_173977839 | 22.48 |
Atp5k-ps2 |
ATP synthase, H+ transporting, mitochondrial F1F0 complex, subunit E, pseudogene 2 |
6932 |
0.22 |
chr1_162886537_162886712 | 22.45 |
Fmo2 |
flavin containing monooxygenase 2 |
109 |
0.96 |
chr13_98942134_98942287 | 22.38 |
Gm35215 |
predicted gene, 35215 |
3706 |
0.16 |
chr2_162987310_162987517 | 22.32 |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
83 |
0.95 |
chr5_25252555_25252731 | 22.23 |
Galnt11 |
polypeptide N-acetylgalactosaminyltransferase 11 |
5280 |
0.18 |
chr19_55700934_55701097 | 22.22 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
40805 |
0.21 |
chr7_99167912_99168273 | 22.18 |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
2014 |
0.23 |
chr5_118488782_118489619 | 22.11 |
Gm15754 |
predicted gene 15754 |
2233 |
0.32 |
chr4_141999596_142000221 | 22.07 |
Fhad1 |
forkhead-associated (FHA) phosphopeptide binding domain 1 |
11729 |
0.12 |
chr5_151176059_151176347 | 22.04 |
Stard13 |
StAR-related lipid transfer (START) domain containing 13 |
13947 |
0.23 |
chr3_149196963_149197145 | 21.90 |
Gm42647 |
predicted gene 42647 |
13217 |
0.22 |
chr2_90565279_90565551 | 21.87 |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
15232 |
0.21 |
chr2_48413105_48413290 | 21.86 |
Gm13472 |
predicted gene 13472 |
25160 |
0.18 |
chr1_164714170_164714528 | 21.78 |
Gm36945 |
predicted gene, 36945 |
1808 |
0.31 |
chr2_63281128_63281298 | 21.74 |
Kcnh7 |
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
96926 |
0.08 |
chr19_57275294_57275488 | 21.66 |
4930449E18Rik |
RIKEN cDNA 4930449E18 gene |
1431 |
0.43 |
chr7_101870689_101871000 | 21.64 |
Folr1 |
folate receptor 1 (adult) |
56 |
0.9 |
chr14_22126327_22126500 | 21.58 |
Gm7480 |
predicted gene 7480 |
90310 |
0.07 |
chr17_43116768_43117140 | 21.44 |
E130008D07Rik |
RIKEN cDNA E130008D07 gene |
41242 |
0.19 |
chr16_21818710_21818992 | 21.44 |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
7091 |
0.12 |
chr16_17945139_17945601 | 21.41 |
Slc25a1 |
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1 |
17151 |
0.09 |
chr1_9985724_9985920 | 21.38 |
Ppp1r42 |
protein phosphatase 1, regulatory subunit 42 |
130 |
0.92 |
chr8_46830076_46830427 | 21.35 |
Gm45481 |
predicted gene 45481 |
3661 |
0.22 |
chr2_35100652_35100811 | 21.34 |
AI182371 |
expressed sequence AI182371 |
42 |
0.97 |
chr7_114322801_114323522 | 21.25 |
Psma1 |
proteasome subunit alpha 1 |
47043 |
0.14 |
chr10_127899960_127900131 | 21.15 |
Sdr9c7 |
4short chain dehydrogenase/reductase family 9C, member 7 |
1270 |
0.27 |
chr6_134664499_134665111 | 21.10 |
Borcs5 |
BLOC-1 related complex subunit 5 |
23550 |
0.12 |
chr10_43441343_43441584 | 21.10 |
Gm3699 |
predicted gene 3699 |
15038 |
0.13 |
chr4_126147482_126148116 | 20.99 |
Eva1b |
eva-1 homolog B (C. elegans) |
55 |
0.95 |
chr11_55465181_55465475 | 20.82 |
Gm12235 |
predicted gene 12235 |
1319 |
0.28 |
chr1_185370083_185370248 | 20.69 |
Eprs |
glutamyl-prolyl-tRNA synthetase |
2568 |
0.16 |
chr17_45964200_45964375 | 20.68 |
Gm49805 |
predicted gene, 49805 |
2428 |
0.28 |
chr8_46409313_46409690 | 20.65 |
Gm45253 |
predicted gene 45253 |
23613 |
0.13 |
chr6_58847151_58847303 | 20.57 |
Herc3 |
hect domain and RLD 3 |
13527 |
0.2 |
chr4_137480764_137481043 | 20.56 |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
12100 |
0.13 |
chr17_80785162_80785354 | 20.52 |
Map4k3 |
mitogen-activated protein kinase kinase kinase kinase 3 |
56773 |
0.12 |
chr17_73142465_73142797 | 20.50 |
Lclat1 |
lysocardiolipin acyltransferase 1 |
16204 |
0.2 |
chr1_63005097_63005262 | 20.48 |
Gm44468 |
predicted gene, 44468 |
20563 |
0.13 |
chr4_132470179_132470330 | 20.24 |
Med18 |
mediator complex subunit 18 |
6333 |
0.11 |
chr12_103956876_103957079 | 20.05 |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
79 |
0.95 |
chrX_101377131_101377323 | 20.04 |
Gjb1 |
gap junction protein, beta 1 |
46 |
0.97 |
chr1_191083622_191083773 | 20.01 |
Gm38188 |
predicted gene, 38188 |
5017 |
0.12 |
chr1_125721555_125721706 | 19.97 |
Gpr39 |
G protein-coupled receptor 39 |
44635 |
0.16 |
chr12_103773603_103773784 | 19.80 |
Serpina1d |
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
101 |
0.94 |
chr11_74464274_74464476 | 19.73 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
56350 |
0.1 |
chr4_35125058_35125826 | 19.72 |
Ifnk |
interferon kappa |
26614 |
0.16 |
chr5_52536992_52537343 | 19.71 |
Gm43685 |
predicted gene 43685 |
1664 |
0.3 |
chr5_137078101_137078252 | 19.70 |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
5908 |
0.12 |
chr12_24686000_24686681 | 19.70 |
Cys1 |
cystin 1 |
4527 |
0.16 |
chr8_68016277_68016428 | 19.65 |
Gm22018 |
predicted gene, 22018 |
6012 |
0.25 |
chr3_104660486_104660785 | 19.55 |
Gm29561 |
predicted gene 29561 |
3504 |
0.12 |
chr9_70934534_70934685 | 19.47 |
Lipc |
lipase, hepatic |
4 |
0.98 |
chr17_15690458_15690609 | 19.46 |
Chd1 |
chromodomain helicase DNA binding protein 1 |
14434 |
0.18 |
chr1_58795307_58795518 | 19.35 |
Casp8 |
caspase 8 |
38 |
0.96 |
chr17_4196817_4197099 | 19.35 |
4930548J01Rik |
RIKEN cDNA 4930548J01 gene |
74845 |
0.12 |
chr8_68279445_68279781 | 19.33 |
Sh2d4a |
SH2 domain containing 4A |
2694 |
0.27 |
chr8_95042426_95042637 | 19.28 |
Gm45757 |
predicted gene 45757 |
3450 |
0.14 |
chr1_91301323_91301486 | 19.26 |
Scly |
selenocysteine lyase |
1393 |
0.28 |
chr14_21096598_21096812 | 19.21 |
Adk |
adenosine kinase |
20553 |
0.2 |
chr5_87568957_87569121 | 19.20 |
Sult1d1 |
sulfotransferase family 1D, member 1 |
12 |
0.96 |
chr19_3832884_3833374 | 19.13 |
Gm19209 |
predicted gene, 19209 |
10740 |
0.09 |
chr14_66654844_66655083 | 18.91 |
Adra1a |
adrenergic receptor, alpha 1a |
19407 |
0.22 |
chr1_136980605_136980905 | 18.89 |
Gm23763 |
predicted gene, 23763 |
9515 |
0.22 |
chr2_4572616_4572816 | 18.87 |
Frmd4a |
FERM domain containing 4A |
6540 |
0.21 |
chr17_66353271_66353455 | 18.86 |
Mtcl1 |
microtubule crosslinking factor 1 |
6818 |
0.19 |
chr17_84650660_84650983 | 18.77 |
Dync2li1 |
dynein cytoplasmic 2 light intermediate chain 1 |
1546 |
0.3 |
chr12_91833685_91833840 | 18.77 |
Sel1l |
sel-1 suppressor of lin-12-like (C. elegans) |
1830 |
0.29 |
chr9_71166429_71166599 | 18.74 |
Aqp9 |
aquaporin 9 |
1119 |
0.45 |
chr1_105178828_105179146 | 18.74 |
Gm29012 |
predicted gene 29012 |
62533 |
0.12 |
chr11_101367389_101367551 | 18.69 |
G6pc |
glucose-6-phosphatase, catalytic |
91 |
0.86 |
chr2_75772672_75773085 | 18.61 |
Gm13657 |
predicted gene 13657 |
4310 |
0.17 |
chr18_56400199_56400368 | 18.60 |
Gramd3 |
GRAM domain containing 3 |
54 |
0.98 |
chr3_52099411_52099566 | 18.48 |
Maml3 |
mastermind like transcriptional coactivator 3 |
5588 |
0.16 |
chr3_146708536_146708739 | 18.47 |
Gm9480 |
predicted gene 9480 |
12418 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.1 | 45.4 | GO:0035483 | gastric emptying(GO:0035483) |
11.1 | 33.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
10.4 | 31.2 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
9.1 | 36.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
8.8 | 35.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
7.2 | 21.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
7.0 | 14.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
6.8 | 20.3 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
6.3 | 37.5 | GO:0015871 | choline transport(GO:0015871) |
6.2 | 18.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
5.7 | 28.4 | GO:1904970 | brush border assembly(GO:1904970) |
4.9 | 19.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
4.5 | 13.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
4.2 | 8.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
4.2 | 16.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
4.1 | 16.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
3.8 | 30.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
3.8 | 15.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
3.5 | 10.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
3.5 | 14.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
3.5 | 10.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
3.5 | 17.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
3.3 | 13.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
3.3 | 39.5 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
3.2 | 19.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
3.2 | 16.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
3.2 | 15.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
3.1 | 9.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
3.0 | 12.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
2.9 | 20.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
2.8 | 8.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
2.7 | 5.5 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
2.7 | 10.9 | GO:0003383 | apical constriction(GO:0003383) |
2.6 | 7.8 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
2.6 | 10.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
2.6 | 2.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
2.6 | 7.7 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
2.5 | 9.9 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
2.5 | 9.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
2.4 | 9.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.4 | 12.1 | GO:0046618 | drug export(GO:0046618) |
2.3 | 18.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.2 | 6.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
2.2 | 2.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
2.2 | 6.6 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
2.2 | 19.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
2.2 | 6.5 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.2 | 2.2 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
2.2 | 6.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.1 | 8.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
2.1 | 6.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.1 | 8.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.1 | 4.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.0 | 6.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.0 | 8.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.0 | 4.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.0 | 6.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
2.0 | 45.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
2.0 | 4.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
2.0 | 7.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.9 | 3.8 | GO:0032898 | neurotrophin production(GO:0032898) |
1.9 | 5.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.9 | 3.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.8 | 7.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.8 | 7.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.8 | 5.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.8 | 3.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
1.8 | 16.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
1.8 | 5.3 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.8 | 8.8 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.7 | 6.9 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.7 | 6.8 | GO:0035627 | ceramide transport(GO:0035627) |
1.7 | 5.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.7 | 6.8 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.7 | 1.7 | GO:0072177 | mesonephric duct development(GO:0072177) |
1.7 | 5.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
1.7 | 5.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.7 | 5.0 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.6 | 6.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.6 | 65.2 | GO:0006953 | acute-phase response(GO:0006953) |
1.6 | 1.6 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.6 | 4.7 | GO:0032439 | endosome localization(GO:0032439) |
1.5 | 4.6 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
1.5 | 6.1 | GO:0007296 | vitellogenesis(GO:0007296) |
1.5 | 4.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
1.5 | 12.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.5 | 3.0 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
1.4 | 4.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.4 | 4.2 | GO:0015888 | thiamine transport(GO:0015888) |
1.3 | 4.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.3 | 2.7 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.3 | 2.7 | GO:0015793 | glycerol transport(GO:0015793) |
1.3 | 8.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.3 | 4.0 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.3 | 5.3 | GO:0060596 | mammary placode formation(GO:0060596) |
1.3 | 10.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.3 | 3.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.3 | 1.3 | GO:0061724 | lipophagy(GO:0061724) |
1.3 | 3.8 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
1.3 | 3.8 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.3 | 7.5 | GO:0051639 | actin filament network formation(GO:0051639) |
1.2 | 3.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.2 | 24.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
1.2 | 3.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.2 | 3.7 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.2 | 2.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.2 | 4.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
1.2 | 4.8 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
1.2 | 3.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.2 | 2.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
1.1 | 4.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.1 | 6.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.1 | 10.8 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.1 | 2.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.1 | 4.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.1 | 32.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
1.0 | 11.5 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
1.0 | 3.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.0 | 4.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.0 | 3.1 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
1.0 | 3.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.0 | 5.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
1.0 | 3.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.0 | 8.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.0 | 4.0 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
1.0 | 6.0 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.0 | 1.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.0 | 1.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.0 | 8.8 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
1.0 | 2.9 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.0 | 3.9 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
1.0 | 3.9 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.0 | 5.7 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.9 | 1.9 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.9 | 4.7 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.9 | 15.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.9 | 5.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.9 | 1.9 | GO:0045472 | response to ether(GO:0045472) |
0.9 | 6.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.9 | 2.8 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.9 | 2.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.9 | 2.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.9 | 0.9 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.9 | 2.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.9 | 7.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.9 | 1.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.9 | 2.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.9 | 9.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.9 | 5.5 | GO:0098856 | intestinal lipid absorption(GO:0098856) |
0.9 | 3.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.9 | 5.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.9 | 2.7 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.9 | 0.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.9 | 2.6 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.9 | 2.6 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.8 | 1.7 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.8 | 5.1 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.8 | 2.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.8 | 3.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.8 | 5.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.8 | 4.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.8 | 2.4 | GO:0060066 | oviduct development(GO:0060066) |
0.8 | 3.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.8 | 1.6 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.8 | 2.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.8 | 1.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.8 | 6.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.8 | 2.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.8 | 2.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.8 | 1.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.7 | 1.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.7 | 2.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.7 | 4.4 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.7 | 2.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.7 | 5.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.7 | 0.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.7 | 2.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.7 | 0.7 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.7 | 4.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.7 | 2.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.7 | 4.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.7 | 5.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.7 | 1.4 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.7 | 3.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 2.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.7 | 3.4 | GO:0019695 | choline metabolic process(GO:0019695) |
0.7 | 1.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 2.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.7 | 1.4 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.7 | 2.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.7 | 3.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.7 | 2.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.7 | 6.6 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.7 | 4.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.7 | 2.0 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.7 | 2.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.7 | 5.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.7 | 5.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.7 | 2.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.7 | 13.7 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.7 | 2.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.6 | 2.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.6 | 1.9 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.6 | 2.6 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.6 | 1.3 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.6 | 3.8 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.6 | 3.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.6 | 1.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.6 | 0.6 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.6 | 2.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.6 | 10.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.6 | 3.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.6 | 4.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 1.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.6 | 1.8 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.6 | 3.6 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.6 | 1.8 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.6 | 1.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.6 | 4.2 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.6 | 5.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.6 | 1.2 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.6 | 3.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.6 | 2.9 | GO:0042737 | drug catabolic process(GO:0042737) |
0.6 | 1.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 | 1.7 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.6 | 1.7 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.6 | 1.2 | GO:0072497 | mesenchymal stem cell differentiation(GO:0072497) |
0.6 | 5.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.6 | 2.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.6 | 4.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.6 | 1.7 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.6 | 4.6 | GO:0060068 | vagina development(GO:0060068) |
0.6 | 2.9 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.6 | 2.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.6 | 1.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 1.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.6 | 1.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 0.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.6 | 1.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 1.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 1.6 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.5 | 2.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.5 | 5.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.5 | 3.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 6.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.5 | 1.1 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.5 | 2.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.5 | 6.5 | GO:0052472 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.5 | 1.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.5 | 1.1 | GO:0048549 | regulation of pinocytosis(GO:0048548) positive regulation of pinocytosis(GO:0048549) |
0.5 | 1.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.5 | 1.6 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 1.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.5 | 0.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.5 | 1.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 0.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.5 | 1.6 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.5 | 18.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.5 | 2.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.5 | 2.6 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 1.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.5 | 2.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.5 | 3.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.5 | 1.0 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.5 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 0.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.5 | 2.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.5 | 1.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 1.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 0.5 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.5 | 2.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.5 | 0.5 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.5 | 2.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.5 | 0.5 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.5 | 1.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.5 | 1.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.5 | 1.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 0.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.5 | 2.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.5 | 2.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.5 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.5 | 0.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 0.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 2.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.5 | 1.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.5 | 1.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 1.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.5 | 1.9 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 4.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 0.9 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.5 | 0.9 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.5 | 0.9 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.5 | 1.4 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.5 | 2.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.5 | 0.9 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.5 | 9.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.5 | 3.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.5 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.5 | 1.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.5 | 1.4 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 4.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.5 | 0.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 12.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.5 | 2.7 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.5 | 1.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.5 | 1.8 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 0.4 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 0.9 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.4 | 0.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 1.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 3.1 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.4 | 1.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 2.6 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.4 | 3.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 0.9 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 3.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 1.3 | GO:0030421 | defecation(GO:0030421) |
0.4 | 3.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.4 | 0.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.4 | 5.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.4 | 2.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 0.8 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.4 | 0.4 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.4 | 0.8 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 0.4 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.4 | 1.7 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.4 | 1.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.4 | 2.9 | GO:0036035 | osteoclast development(GO:0036035) |
0.4 | 2.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.4 | 2.5 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.4 | 0.4 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 4.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 0.8 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 4.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 1.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 1.6 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.4 | 4.5 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.4 | 1.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.4 | 0.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.4 | 4.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.4 | 2.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 3.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.4 | 2.0 | GO:0000237 | leptotene(GO:0000237) |
0.4 | 2.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.4 | 9.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 1.2 | GO:0008050 | female courtship behavior(GO:0008050) |
0.4 | 1.2 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 0.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 1.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 0.4 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.4 | 6.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 0.8 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.4 | 1.9 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 8.1 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.4 | 0.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.4 | 2.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 0.4 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.4 | 3.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 0.8 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.4 | 65.6 | GO:0043434 | response to peptide hormone(GO:0043434) |
0.4 | 0.8 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.4 | 3.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 8.7 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 0.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 1.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 1.1 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
0.4 | 0.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 1.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.4 | 0.4 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.4 | 0.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 1.1 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.4 | 0.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.4 | 5.6 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 1.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.4 | 0.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.4 | 1.1 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.4 | 1.5 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.4 | 1.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.4 | 1.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.4 | 1.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.4 | 1.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 2.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 1.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 0.4 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.4 | 9.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.4 | 4.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.4 | 3.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.4 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.4 | 1.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 2.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.4 | 3.2 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.4 | 3.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.4 | 3.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.4 | 1.8 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.4 | 1.8 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 3.2 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.3 | 2.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.7 | GO:0033206 | meiotic cytokinesis(GO:0033206) chromosome movement towards spindle pole(GO:0051305) |
0.3 | 1.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 0.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 1.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 2.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 2.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.3 | 3.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 3.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 2.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 0.7 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 1.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 2.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 10.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 10.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 4.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.3 | 1.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 3.7 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.3 | 2.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 1.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 12.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.3 | 1.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 0.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 4.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.3 | 1.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 2.9 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 1.0 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 6.1 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 1.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 2.9 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 2.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 13.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.3 | 1.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.3 | 1.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.3 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.3 | 0.9 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.3 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 1.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 0.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.3 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 8.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.3 | 0.3 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 1.2 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.3 | 8.9 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.3 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 0.6 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.3 | 1.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 1.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 1.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 1.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 0.6 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 3.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 1.5 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 0.6 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.3 | 0.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 0.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.3 | 0.9 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 2.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 0.9 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.3 | 0.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 0.6 | GO:1901679 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.3 | 9.4 | GO:0033141 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 1.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 1.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.9 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.3 | 0.3 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.3 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 4.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 2.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.3 | 1.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 5.4 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 1.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 1.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 2.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 0.3 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) |
0.3 | 1.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 13.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 1.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 2.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 2.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 2.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 3.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 1.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.3 | 3.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.3 | 19.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 25.0 | GO:0050817 | coagulation(GO:0050817) |
0.3 | 6.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.6 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.3 | 0.3 | GO:0071868 | cellular response to monoamine stimulus(GO:0071868) |
0.3 | 4.3 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.3 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.3 | 0.5 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
0.3 | 0.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 0.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.3 | 2.9 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 0.8 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 2.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.3 | 0.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 24.7 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.3 | 3.6 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.3 | 3.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 1.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 2.1 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.3 | 0.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.3 | 1.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.3 | 1.3 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 1.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.3 | 0.5 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.3 | 3.8 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.3 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 3.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 10.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 1.2 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.2 | 0.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 1.5 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.2 | 1.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 5.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 0.5 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 1.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.5 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 2.1 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 1.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 11.1 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.2 | 0.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.2 | 1.9 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.2 | 0.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.2 | 0.7 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 0.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.2 | 0.5 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.2 | 0.2 | GO:0034384 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) high-density lipoprotein particle clearance(GO:0034384) |
0.2 | 2.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 1.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.2 | 1.6 | GO:0032528 | microvillus organization(GO:0032528) |
0.2 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 4.8 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 1.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.5 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 1.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 1.8 | GO:0051923 | sulfation(GO:0051923) |
0.2 | 5.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.2 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.2 | 1.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.4 | GO:0015810 | aspartate transport(GO:0015810) |
0.2 | 1.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.2 | 2.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 1.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.2 | 4.7 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.2 | 3.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.2 | 1.8 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 1.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 4.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 2.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.2 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.7 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.2 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.2 | 6.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 4.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 0.4 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.2 | 4.7 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.2 | 1.1 | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.2 | 1.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.2 | 1.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 4.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.2 | GO:0034238 | macrophage fusion(GO:0034238) |
0.2 | 1.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 2.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 1.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.2 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.2 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 5.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.2 | 1.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 11.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 0.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.6 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 5.3 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.2 | 0.6 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 1.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.2 | 0.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.4 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 1.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 0.4 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 1.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.4 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.2 | 0.4 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.2 | 2.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.6 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.2 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.4 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.2 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 4.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.2 | 0.4 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.2 | 0.2 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.2 | 0.8 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 5.1 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.2 | 0.9 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 3.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.2 | 0.8 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.4 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.6 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 0.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.2 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.2 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.4 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.2 | 0.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.7 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 1.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.2 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.2 | 0.7 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 0.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.2 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.2 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.2 | 1.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 | 0.4 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.2 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.9 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.2 | 1.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 7.4 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.2 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 13.2 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.2 | 0.9 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 8.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 1.6 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.2 | 2.6 | GO:0034340 | response to type I interferon(GO:0034340) |
0.2 | 0.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 1.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.5 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 1.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.2 | 0.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 0.2 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.2 | 7.4 | GO:0048477 | oogenesis(GO:0048477) |
0.2 | 1.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 0.3 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.2 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 4.3 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.2 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 0.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.5 | GO:0043328 | endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 1.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.2 | 5.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.3 | GO:0090086 | regulation of protein deubiquitination(GO:0090085) negative regulation of protein deubiquitination(GO:0090086) |
0.2 | 0.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 3.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.5 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 0.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.2 | 1.6 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 0.9 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.2 | 2.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 3.0 | GO:0001825 | blastocyst formation(GO:0001825) |
0.2 | 1.8 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.2 | 1.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.3 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 1.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 3.5 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.3 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 2.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 1.6 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.7 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.1 | 1.3 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 2.6 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0000423 | macromitophagy(GO:0000423) |
0.1 | 0.3 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.3 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 0.3 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.8 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 3.7 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 6.0 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 1.4 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 1.8 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.9 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.1 | GO:0032762 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) |
0.1 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 3.2 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 1.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.1 | 2.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.7 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 2.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.7 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 2.3 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 1.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.4 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.1 | 0.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 1.9 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 1.3 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.4 | GO:0032049 | cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) |
0.1 | 1.3 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.4 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.1 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 1.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 1.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.6 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 1.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.2 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 5.1 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.9 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 0.4 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.6 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.6 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.6 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 1.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 1.4 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 1.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.1 | 0.1 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 1.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 1.0 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.1 | 0.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 3.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.2 | GO:1903580 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.1 | 0.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 1.0 | GO:0009206 | ATP biosynthetic process(GO:0006754) purine nucleoside triphosphate biosynthetic process(GO:0009145) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 1.1 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 1.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 1.8 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.7 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.4 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.2 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.5 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.2 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.2 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.5 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 2.5 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 1.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 1.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:0010421 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) |
0.1 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.7 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.3 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 0.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.1 | 1.8 | GO:0048814 | regulation of dendrite morphogenesis(GO:0048814) |
0.1 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 1.7 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.2 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.2 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.3 | GO:0071549 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.5 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.6 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.2 | GO:0032536 | regulation of cell projection size(GO:0032536) |
0.1 | 0.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.2 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 1.5 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 0.1 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.2 | GO:0098764 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 2.1 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.5 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.4 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 1.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.3 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
0.1 | 0.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.2 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.5 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:0034311 | diol metabolic process(GO:0034311) |
0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.8 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 1.4 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
0.1 | 0.2 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.2 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.1 | 6.9 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 1.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.2 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.1 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.1 | 1.0 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 2.5 | GO:0034329 | cell junction assembly(GO:0034329) |
0.1 | 0.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 1.7 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.1 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.6 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.1 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.1 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.1 | 0.2 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.1 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) regulation of T-helper 2 cell differentiation(GO:0045628) |
0.1 | 0.2 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.1 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.1 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.1 | 0.3 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
0.1 | 0.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.3 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.6 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 0.3 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.4 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.1 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.1 | GO:1903961 | positive regulation of inorganic anion transmembrane transport(GO:1903797) positive regulation of anion transmembrane transport(GO:1903961) |
0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 2.4 | GO:0048771 | tissue remodeling(GO:0048771) |
0.1 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.8 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.2 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 0.1 | GO:0003157 | endocardium development(GO:0003157) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 1.0 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.2 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.3 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.1 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.3 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.6 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.5 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.5 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 1.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.3 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.1 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.6 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.3 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 0.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.5 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.2 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.1 | GO:0098751 | bone cell development(GO:0098751) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 2.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.4 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.5 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 0.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.8 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.1 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.4 | GO:1901652 | response to peptide(GO:1901652) |
0.1 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.3 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.6 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.1 | 0.2 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.1 | 0.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.3 | GO:0042168 | heme metabolic process(GO:0042168) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.2 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.1 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 1.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.2 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.2 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.1 | 0.1 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.1 | 1.1 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.1 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.3 | GO:0030917 | rostrocaudal neural tube patterning(GO:0021903) midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 0.1 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.1 | 0.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.2 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.4 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:0007595 | lactation(GO:0007595) |
0.1 | 3.7 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.5 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.1 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 1.4 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.1 | GO:0010935 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 1.1 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) |
0.1 | 0.2 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.5 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 0.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.8 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) |
0.1 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.1 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 0.3 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.4 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 2.8 | GO:0044744 | protein import into nucleus(GO:0006606) protein targeting to nucleus(GO:0044744) single-organism nuclear import(GO:1902593) |
0.0 | 0.4 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 1.1 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.0 | 0.3 | GO:0045471 | response to ethanol(GO:0045471) |
0.0 | 0.2 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.3 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.0 | 0.1 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.0 | 0.0 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.2 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 2.0 | GO:0018108 | peptidyl-tyrosine phosphorylation(GO:0018108) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.2 | GO:0090220 | telomere localization(GO:0034397) meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.7 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 0.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.8 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.0 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.1 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.0 | 0.3 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.3 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.0 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.5 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.0 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 1.2 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.2 | GO:0034502 | protein localization to chromosome(GO:0034502) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 3.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 2.9 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.0 | 0.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0042594 | response to starvation(GO:0042594) |
0.0 | 0.0 | GO:0060931 | cardiac pacemaker cell development(GO:0060926) sinoatrial node cell development(GO:0060931) |
0.0 | 0.2 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.2 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.8 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 1.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.0 | 0.5 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 0.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.0 | 0.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.0 | GO:0031669 | cellular response to nutrient levels(GO:0031669) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.2 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0070663 | regulation of leukocyte proliferation(GO:0070663) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.2 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.5 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 0.0 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.0 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.1 | GO:0045931 | positive regulation of mitotic cell cycle(GO:0045931) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.0 | 0.0 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.0 | 0.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.0 | GO:1902930 | regulation of alcohol biosynthetic process(GO:1902930) |
0.0 | 0.1 | GO:0015748 | organophosphate ester transport(GO:0015748) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:1990182 | exosomal secretion(GO:1990182) |
0.0 | 0.0 | GO:0051647 | nucleus localization(GO:0051647) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.7 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.0 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.1 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 2.9 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.2 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.1 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0097205 | renal filtration(GO:0097205) |
0.0 | 0.3 | GO:0001756 | somitogenesis(GO:0001756) |
0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.2 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.0 | 0.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.0 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 1.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.1 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.1 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.0 | 0.0 | GO:0006837 | serotonin transport(GO:0006837) |
0.0 | 0.0 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.0 | 0.1 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.0 | 0.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.0 | GO:0071025 | RNA surveillance(GO:0071025) |
0.0 | 0.1 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.6 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0052652 | cyclic nucleotide biosynthetic process(GO:0009190) cyclic purine nucleotide metabolic process(GO:0052652) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.1 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.0 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.0 | 0.0 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.0 | 0.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.0 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.0 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.1 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.0 | 0.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.0 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.0 | 0.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.1 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:2000192 | negative regulation of icosanoid secretion(GO:0032304) negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.0 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.0 | 0.5 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.0 | 0.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.2 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.0 | 0.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.2 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.0 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) mineralocorticoid biosynthetic process(GO:0006705) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.1 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.3 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.6 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0014741 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.0 | 0.0 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.1 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.0 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.0 | 0.0 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.0 | 0.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 4.0 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.5 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.0 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.0 | 0.0 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.0 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.0 | 0.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.0 | 0.1 | GO:0032845 | negative regulation of homeostatic process(GO:0032845) |
0.0 | 0.0 | GO:0032768 | regulation of monooxygenase activity(GO:0032768) |
0.0 | 0.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0045606 | positive regulation of epidermal cell differentiation(GO:0045606) |
0.0 | 0.0 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.0 | 0.0 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.0 | 0.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.0 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.3 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 0.0 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.0 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.0 | 0.0 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.0 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.0 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.0 | GO:0042181 | ketone biosynthetic process(GO:0042181) |
0.0 | 0.0 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.1 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.0 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.0 | GO:1903523 | negative regulation of blood circulation(GO:1903523) |
0.0 | 0.2 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.0 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.0 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.0 | 0.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.0 | 0.0 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.0 | 0.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.0 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0046782 | regulation of viral transcription(GO:0046782) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 29.0 | GO:0031983 | vesicle lumen(GO:0031983) |
4.7 | 18.7 | GO:0030689 | Noc complex(GO:0030689) |
4.6 | 27.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
4.3 | 29.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
3.7 | 14.9 | GO:0045293 | mRNA editing complex(GO:0045293) |
3.5 | 20.9 | GO:0002177 | manchette(GO:0002177) |
3.3 | 13.2 | GO:0042583 | chromaffin granule(GO:0042583) |
2.9 | 11.6 | GO:0033269 | internode region of axon(GO:0033269) |
2.9 | 8.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.6 | 10.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
2.4 | 4.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
2.3 | 6.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
2.0 | 5.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.9 | 13.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.9 | 5.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.8 | 12.8 | GO:0005688 | U6 snRNP(GO:0005688) |
1.8 | 5.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.7 | 10.4 | GO:0005915 | zonula adherens(GO:0005915) |
1.6 | 23.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
1.6 | 6.4 | GO:0098536 | deuterosome(GO:0098536) |
1.6 | 9.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
1.6 | 18.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.5 | 6.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.3 | 26.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.3 | 5.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.2 | 6.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.2 | 3.5 | GO:0097427 | microtubule bundle(GO:0097427) |
1.1 | 3.3 | GO:0031523 | Myb complex(GO:0031523) |
1.1 | 5.4 | GO:0097255 | R2TP complex(GO:0097255) |
1.1 | 3.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.1 | 10.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.1 | 10.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.0 | 2.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.0 | 3.1 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) |
1.0 | 7.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 19.4 | GO:0005922 | connexon complex(GO:0005922) |
0.9 | 1.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.9 | 4.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.9 | 3.5 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.9 | 3.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.8 | 5.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 2.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.8 | 4.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 0.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.8 | 3.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 5.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.8 | 2.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.7 | 3.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.7 | 2.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.7 | 41.2 | GO:0005903 | brush border(GO:0005903) |
0.7 | 41.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.7 | 4.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.7 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.7 | 5.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.7 | 3.9 | GO:0070847 | core mediator complex(GO:0070847) |
0.6 | 1.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.6 | 5.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.6 | 7.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.6 | 2.9 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.6 | 1.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.6 | 5.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.5 | 1.6 | GO:0000811 | GINS complex(GO:0000811) |
0.5 | 8.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.5 | 4.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 5.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 3.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.5 | 4.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.5 | 6.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.5 | 4.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.5 | 27.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.5 | 1.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.5 | 1.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 2.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 1.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.5 | 3.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 1.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.5 | 2.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 13.5 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 9.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.5 | 8.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.5 | 0.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.5 | 6.5 | GO:0005605 | basal lamina(GO:0005605) |
0.5 | 1.8 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 0.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 1.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 2.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.4 | 1.3 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 3.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.4 | 0.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 2.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.4 | 16.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.4 | 2.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 1.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 3.2 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.4 | 5.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 3.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 1.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.4 | 1.6 | GO:0002141 | stereocilia ankle link(GO:0002141) |
0.4 | 2.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 3.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.4 | 1.5 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 0.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 4.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.4 | 1.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 1.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.4 | 0.7 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 0.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 15.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.4 | 26.6 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 2.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 15.5 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.4 | 0.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 7.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 5.0 | GO:0005813 | centrosome(GO:0005813) |
0.4 | 2.9 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 14.3 | GO:0030286 | dynein complex(GO:0030286) |
0.4 | 3.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.4 | 1.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 1.8 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 17.6 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 20.6 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 1.7 | GO:0005770 | late endosome(GO:0005770) |
0.3 | 2.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 4.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 55.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.3 | 3.8 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 1.3 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 5.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 13.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.3 | 0.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.3 | 1.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.3 | 3.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 5.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 24.2 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.3 | 1.3 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 5.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.3 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.3 | 0.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 15.2 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 1.9 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 2.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 2.1 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 5.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 2.6 | GO:0043235 | receptor complex(GO:0043235) |
0.3 | 1.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 0.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 4.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 2.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 12.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 2.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 2.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 22.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 17.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 5.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 21.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.3 | 1.6 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 1.3 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.3 | 24.8 | GO:0005769 | early endosome(GO:0005769) |
0.3 | 0.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 0.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 27.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
0.3 | 254.0 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.3 | 9.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 3.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 2.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 3.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.2 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 0.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 5.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.9 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 1.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 66.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 3.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 0.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.9 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 6.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 1.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.2 | 0.2 | GO:1904949 | ATPase complex(GO:1904949) |
0.2 | 8.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 2.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 2.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 2.9 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 9.0 | GO:0005768 | endosome(GO:0005768) |
0.2 | 1.4 | GO:0072686 | mitotic spindle(GO:0072686) |
0.2 | 3.1 | GO:0012505 | endomembrane system(GO:0012505) |
0.2 | 2.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 9.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 2.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 1.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 6.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 3.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 41.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.2 | 0.6 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 2.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 8.8 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.2 | 0.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 40.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 2.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 10.1 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 1.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 2.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 4.0 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 1.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 9.7 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 1.9 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 0.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 4.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 3.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 2.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 0.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 1.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.0 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.9 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.1 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 1.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 2.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.3 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 6.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 2.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.6 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 157.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 1.0 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 0.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.6 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 17.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 0.7 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 6.2 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 6.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 59.6 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 3.7 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 2.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 1.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.5 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.7 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 2.7 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 107.9 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 12.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 7.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.0 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 2.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.3 | GO:0044437 | vacuolar part(GO:0044437) |
0.1 | 0.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.2 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 76.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 31.8 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 1.0 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.2 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.1 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 239.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 1.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.0 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.6 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.1 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.2 | GO:0070187 | telosome(GO:0070187) |
0.0 | 0.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.0 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 115.4 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 38.6 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 4.4 | GO:0016020 | membrane(GO:0016020) |
0.0 | 0.0 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0005856 | cytoskeleton(GO:0005856) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.4 | 37.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
6.5 | 19.6 | GO:0051870 | methotrexate binding(GO:0051870) |
6.5 | 32.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
6.4 | 25.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
6.3 | 18.8 | GO:0035877 | death effector domain binding(GO:0035877) |
5.6 | 16.9 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
5.5 | 27.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
5.5 | 43.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
5.2 | 20.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
3.6 | 10.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
3.2 | 28.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
3.1 | 46.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
3.0 | 9.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
2.7 | 16.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
2.5 | 30.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
2.5 | 12.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
2.4 | 9.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
2.4 | 9.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.3 | 6.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
2.2 | 8.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.1 | 6.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
2.1 | 10.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.0 | 5.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.9 | 15.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.9 | 7.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.8 | 5.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.8 | 5.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.8 | 8.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.7 | 5.1 | GO:0008142 | oxysterol binding(GO:0008142) |
1.7 | 5.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.6 | 8.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.6 | 7.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.6 | 6.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.5 | 7.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.5 | 23.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.4 | 20.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.4 | 15.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.4 | 141.2 | GO:0001948 | glycoprotein binding(GO:0001948) |
1.3 | 4.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.3 | 6.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.3 | 5.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.3 | 7.9 | GO:0030274 | LIM domain binding(GO:0030274) |
1.3 | 2.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.3 | 6.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.2 | 2.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.2 | 3.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.2 | 14.3 | GO:0008758 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
1.1 | 4.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.1 | 4.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.1 | 14.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.1 | 10.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.1 | 5.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
1.0 | 4.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.0 | 2.1 | GO:0038191 | neuropilin binding(GO:0038191) |
1.0 | 3.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.0 | 31.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.0 | 4.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.0 | 6.9 | GO:0046790 | virion binding(GO:0046790) |
1.0 | 36.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.0 | 2.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.0 | 3.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.0 | 2.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.0 | 3.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.0 | 3.8 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.0 | 18.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.9 | 2.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 3.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.9 | 2.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.9 | 5.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.9 | 5.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.9 | 4.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.9 | 6.3 | GO:0018646 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.9 | 7.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.9 | 2.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.9 | 2.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.8 | 15.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.8 | 24.1 | GO:0045502 | dynein binding(GO:0045502) |
0.8 | 4.9 | GO:0034944 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.8 | 2.5 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.8 | 4.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.8 | 2.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.8 | 4.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.8 | 6.3 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.8 | 3.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.8 | 2.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.8 | 8.5 | GO:0051735 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.8 | 3.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 2.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.7 | 8.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.7 | 8.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.7 | 25.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.7 | 3.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 3.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.7 | 2.2 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.7 | 3.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.7 | 2.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.7 | 7.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.7 | 3.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.7 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.7 | 2.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.7 | 8.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 3.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.7 | 2.1 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.7 | 2.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.7 | 12.9 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.7 | 2.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 5.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 3.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 1.9 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.6 | 4.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 1.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.6 | 4.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 0.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 6.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.6 | 1.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.6 | 2.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 1.9 | GO:0070905 | serine binding(GO:0070905) |
0.6 | 3.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.6 | 1.8 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.6 | 3.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.6 | 4.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 6.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.6 | 10.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.6 | 1.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 7.0 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.6 | 0.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.6 | 2.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.6 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.6 | 1.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.6 | 3.4 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.6 | 1.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 2.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.6 | 2.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.6 | 0.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.6 | 0.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.6 | 5.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 3.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.6 | 2.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.6 | 1.7 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 3.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.5 | 15.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.5 | 21.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.5 | 2.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.5 | 2.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 1.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.5 | 2.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 1.6 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 1.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.5 | 1.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 12.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.5 | 6.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.5 | 6.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 4.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.5 | 15.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.5 | 6.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 2.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 7.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 3.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.5 | 1.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 2.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.5 | 2.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.5 | 4.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 2.9 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 3.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.5 | 0.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 0.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 29.5 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.5 | 1.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.5 | 1.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 8.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 0.9 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.4 | 6.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 7.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.7 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.4 | 1.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 14.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 9.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.4 | 1.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.4 | 1.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 1.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 10.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.4 | 10.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.4 | 1.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 2.5 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 6.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.4 | 6.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.4 | 2.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 1.2 | GO:0034618 | arginine binding(GO:0034618) |
0.4 | 2.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.4 | 2.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 5.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.4 | 1.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 1.9 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 7.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.4 | 1.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 1.9 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.4 | 1.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 26.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.4 | 1.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 1.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 2.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 3.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 2.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.4 | 1.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 5.8 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 1.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 1.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.4 | 6.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.4 | 2.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 1.8 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 1.4 | GO:0048185 | activin binding(GO:0048185) |
0.4 | 2.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 2.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 7.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 1.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.3 | 4.9 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 6.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 1.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 3.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 1.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 2.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 4.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 0.7 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 0.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 5.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 1.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 9.1 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 0.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.3 | 2.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 5.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.9 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.3 | 13.0 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.3 | 11.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 1.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 5.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 2.8 | GO:0060229 | lipase activator activity(GO:0060229) |
0.3 | 4.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 2.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 9.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 6.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 2.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.3 | 5.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 0.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 1.2 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 0.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 31.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 5.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 0.3 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.3 | 2.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 4.0 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 3.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 2.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 0.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.3 | 8.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.3 | 2.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 1.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 0.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 3.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 2.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 0.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 15.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 2.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.3 | 0.8 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.3 | 4.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 3.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 0.8 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 0.5 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.3 | 1.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 1.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 1.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 1.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 3.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 3.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 6.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 5.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 0.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.3 | 2.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 2.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 0.3 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.3 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 8.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 0.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 0.3 | GO:0030352 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.3 | 10.2 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.3 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 19.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.3 | 1.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 2.3 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.3 | 1.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.3 | 1.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 1.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 16.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 22.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.7 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 2.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 1.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 2.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 1.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 6.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 1.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 31.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.2 | 1.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.7 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.2 | 0.9 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 3.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 4.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 2.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.2 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 1.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 24.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.2 | 6.5 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.9 | GO:0019213 | deacetylase activity(GO:0019213) |
0.2 | 7.0 | GO:0016597 | amino acid binding(GO:0016597) |
0.2 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 5.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 6.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 16.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.2 | 5.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 1.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 1.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.6 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 2.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 3.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.6 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 1.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.4 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 0.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 4.6 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 0.6 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 4.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 3.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 6.7 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 2.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 36.9 | GO:0005543 | phospholipid binding(GO:0005543) |
0.2 | 0.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 2.3 | GO:0042562 | hormone binding(GO:0042562) |
0.2 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 3.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 8.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.2 | 3.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 3.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 3.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 4.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 1.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.7 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.5 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.2 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 1.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.5 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.2 | 0.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 1.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.2 | 7.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 0.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 3.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 1.4 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 5.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 9.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.7 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 1.8 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 0.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 1.9 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.2 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 2.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.2 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.2 | 22.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 1.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 1.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 1.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 1.8 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 3.4 | GO:0019905 | syntaxin binding(GO:0019905) |
0.2 | 8.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.2 | 1.4 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.2 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.6 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.2 | 1.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.0 | GO:0052688 | succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.6 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.3 | GO:0015464 | acetylcholine-activated cation-selective channel activity(GO:0004889) acetylcholine receptor activity(GO:0015464) |
0.1 | 1.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 2.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 1.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.9 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 5.1 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 2.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 7.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 0.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 2.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 1.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 22.9 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 0.5 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 68.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 4.6 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 4.9 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 6.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 3.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 1.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.5 | GO:0035586 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) purinergic receptor activity(GO:0035586) |
0.1 | 2.4 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 5.8 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 1.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 2.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 1.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.9 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.5 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 6.2 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 0.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 28.5 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 0.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 1.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.5 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 1.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 5.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 8.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 2.3 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.7 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 1.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 6.1 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 0.6 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 2.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 4.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 2.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 1.9 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 1.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 10.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 1.0 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.8 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.3 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 4.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 8.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 1.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.4 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 2.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.9 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 59.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 1.6 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 1.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.6 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.1 | 0.9 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.9 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.5 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 3.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 3.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 0.2 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.1 | 0.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 3.5 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 3.2 | GO:0008289 | lipid binding(GO:0008289) |
0.1 | 2.3 | GO:0005254 | chloride channel activity(GO:0005254) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0102345 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 3.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 3.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 1.5 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.1 | GO:0036435 | IkappaB kinase activity(GO:0008384) K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.2 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 5.0 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.1 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 7.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 5.2 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.0 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.0 | 0.7 | GO:0052693 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.0 | GO:0070061 | fructose binding(GO:0070061) |
0.0 | 0.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.8 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0052849 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 4.5 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.0 | 0.1 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 2.5 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.0 | 0.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 4.1 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 1.0 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.0 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.8 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 2.4 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 0.0 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.1 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:0016877 | ligase activity, forming carbon-sulfur bonds(GO:0016877) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.0 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.4 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.0 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 0.0 | GO:0010851 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 15.2 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.0 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0070697 | activin receptor binding(GO:0070697) |
0.0 | 0.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.0 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 101.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.5 | 11.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.4 | 34.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.4 | 35.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.1 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.1 | 10.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.0 | 28.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.9 | 50.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.9 | 1.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.8 | 29.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.8 | 3.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.7 | 20.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 25.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.7 | 5.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 1.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.6 | 5.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 25.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.6 | 7.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.6 | 15.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 12.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 9.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 2.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.5 | 15.4 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 17.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 34.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 4.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 2.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 6.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.5 | 1.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 12.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.5 | 8.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 57.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 5.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 5.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 14.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 2.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 4.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 5.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 1.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 11.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 14.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 1.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 1.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 5.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 1.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 3.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 10.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 0.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 1.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 1.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 9.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 2.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 2.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 5.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 9.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 3.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 1.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 1.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 1.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 6.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 2.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 6.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 4.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 32.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 5.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 4.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 3.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 39.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 5.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 1.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 1.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 1.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 4.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 6.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 4.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 2.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 1.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 2.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 0.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 5.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 1.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 5.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 4.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 2.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 18.3 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 1.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.9 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 57.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
3.4 | 40.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
3.1 | 56.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
2.4 | 46.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
2.4 | 23.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
2.1 | 21.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
2.1 | 33.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.9 | 5.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.9 | 41.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.8 | 21.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.7 | 20.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.7 | 13.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.6 | 4.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.6 | 15.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.5 | 2.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.2 | 18.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.1 | 9.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.0 | 13.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.0 | 14.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.0 | 11.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.0 | 2.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.0 | 11.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.0 | 10.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.0 | 13.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.0 | 8.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.9 | 14.6 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.9 | 6.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.8 | 9.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.8 | 2.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 24.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.8 | 11.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.8 | 31.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.8 | 4.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.7 | 6.6 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.7 | 10.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.7 | 28.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.7 | 10.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 8.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 9.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 4.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.6 | 12.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 10.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.6 | 38.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 4.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.5 | 14.5 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.5 | 19.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.5 | 6.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 8.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 5.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 3.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 6.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.5 | 8.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 0.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.5 | 8.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 8.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.5 | 5.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 6.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 3.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.4 | 11.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.4 | 6.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.4 | 13.4 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.4 | 4.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 5.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 7.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 11.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.4 | 11.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 6.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.4 | 3.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 3.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 4.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.4 | 1.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 14.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.4 | 11.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 1.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.4 | 7.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 2.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 4.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 20.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 6.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 4.3 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.3 | 3.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 6.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.3 | 0.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 9.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 30.7 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.3 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 6.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 2.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 3.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 6.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 2.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 12.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 3.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 0.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 11.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 1.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 1.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 16.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 0.8 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 1.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 56.9 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.2 | 3.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 3.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 7.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 5.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 11.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 2.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 12.7 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.2 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 0.9 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.2 | 10.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 3.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 0.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 1.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 2.4 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 2.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 3.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 2.7 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.2 | 1.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 11.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 2.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 0.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 10.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 3.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 0.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 0.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 0.7 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 4.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.5 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.2 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 6.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 2.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 5.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 3.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 2.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.8 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 5.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 2.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 3.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 1.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 2.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.0 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 1.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 4.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 3.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.5 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 1.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.1 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.1 | 1.1 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.8 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 2.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 0.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.4 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 2.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 3.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.5 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.1 | 1.8 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.2 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.0 | 2.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.0 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |